Main menu button

Actualités

Analysis Follicum: Countdown to new hair loss trials
05 Déc 2019
Analysis Follicum: Countdown to new hair loss trials
Equity Research
Analysis MultiDocker: Divestment of Brazilian subsidiary adds cash
05 Déc 2019
Analysis MultiDocker: Divestment of Brazilian subsidiary adds cash
Equity Research
Analysis Cantargia: Surprisingly strong data
03 Déc 2019
Analysis Cantargia: Surprisingly strong data
Equity Research
Analysis Consilium: Slightly better than anticipated in Q3 2019
02 Déc 2019
Analysis Consilium: Slightly better than anticipated in Q3 2019
Equity Research
Analysis Ecoclime: Focus to sell energy saving products
25 Nov 2019
Analysis Ecoclime: Focus to sell energy saving products
Equity Research
Analysis Amasten: Increased focus following divestment
21 Nov 2019
Analysis Amasten: Increased focus following divestment
Equity Research
Analysis Expres2ion: Good potential with reduced risk
21 Nov 2019
Analysis Expres2ion: Good potential with reduced risk
Equity Research
Analysis Flowscape: Break-even reached
20 Nov 2019
Analysis Flowscape: Break-even reached
Equity Research
Analysis Precise Biometrics: Approaching profitability
18 Nov 2019
Analysis Precise Biometrics: Approaching profitability
Equity Research
Analysis Aspire: Attractive valuation
13 Nov 2019
Analysis Aspire: Attractive valuation
Equity Research
Analysis, Verisec: Freja eID increasing its pace
12 Nov 2019
Analysis, Verisec: Freja eID increasing its pace
Equity Research
Carlsquare advised on Bifodan's sale to Deerland Probiotics & Enzymes
12 Nov 2019
Carlsquare advised on Bifodan's sale to Deerland Probiotics & Enzymes
Deal News
Carlsquare advised on Bifodan's sale to Deerland Probiotics & Enzymes
12 Nov 2019
Carlsquare advised on Bifodan's sale to Deerland Probiotics & Enzymes
Deal News
Carlsquare advised on Bifodan's sale to Deerland Probiotics & Enzymes
12 Nov 2019
Carlsquare advised on Bifodan's sale to Deerland Probiotics & Enzymes
Deal News
Analysis Fastator: No NAV discount following share price increase
11 Nov 2019
Analysis Fastator: No NAV discount following share price increase
Equity Research
Analysis, Bioservo: Bright future ahead
08 Nov 2019
Analysis, Bioservo: Bright future ahead
Equity Research
Analysis, New Wave Group: Increased focus on profitability
08 Nov 2019
Analysis, New Wave Group: Increased focus on profitability
Equity Research
Analysis Saniona: Appetizing results
05 Nov 2019
Analysis Saniona: Appetizing results
Equity Research
Analysis SpectraCure: Accelerated approval would add value
04 Nov 2019
Analysis SpectraCure: Accelerated approval would add value
Equity Research
Analysis Netmore: Revenue growth indicates right path
01 Nov 2019
Analysis Netmore: Revenue growth indicates right path
Equity Research